|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetics of imatinib mesylate in end stage renal disease:A case study 显示文摘 | pappaps P Karavasilis V Briasoulis E | 2005 | Cancer Chemother Pharmacol2005，56，： | 1 |
| 2 | Diagnostic and therapeutic management of cancer of an unknown primary显示文摘 | Pavlidis N Briasoulis E Hainsworth J | 2003 | Eur J Cancer2003，39，14： | 1 |
| 3 | The neutrophil, not the tumor, serum CA15-3 elevation as a result of granuloeyte-colony-stimulating factor-induced neutrophil MUC1 overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy 显示文摘 | Pentheroudakis G Malamou-Mitsi V Briasoulis E | 2004 | Cancer2004，101，8： | 1 |
| 4 | The neutrophil, not the tumor, serum CA15-3 elevation as a result of granuloeyte-colony-stimulating factor-induced neutrophil MUC1 overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy 显示文摘 | Pentheroudakis G Malamou-Mitsi V Briasoulis E | 2004 | Cancer2004，101，8： | 1 |
| 5 | Clinicopathologic study of vascular endothelial growth factor,thrombospondin-1,and microvessel density assessed by CD34 in patients with stage Ⅲ ovarian carcinoma显示文摘 | Karavasilis V Malamou-Mitsi V Briasoulis E | 2006 | Int J Gynecol Cancer2006，16，： | 1 |
| 6 | Individualized preventive and therapeutic management of hereditary breast ovarian canc- er syndrome显示文摘 | Roukos DH Briasoulis E | 2007 | Nat Clin Pract Oncol2007，4，10： | 1 |
| 7 | Clinicopathological study of the expression of hsp27 , ps2, cathepsin D and metallothionein in primary invasive breast cancer 显示文摘 | Ioachim E Taanou E Briasoulis E | 2003 | Breast2003，12，2： | 1 |
| 8 | Noncardiogenic pulmonary edema:an unusual and serious complication of antieaneer therapy显示文摘 | Pavlidis N | 2001 | Oneologist2001，6，2： | 1 |
| 9 | Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metal othionein in primary invasive breast cancer显示文摘 | Ioachim E Tsanou E Briasoulis E | 2003 | Breast2003，12，2： | 1 |
| 10 | Immunohistochemical expression of extracellular matrix components tenascin,fibronectin,collagen type Ⅳ and laminin in breast cancer:their prognostic value and role in tumour invasion and progression显示文摘 | IOACHIM E CHARCHANTI A BRIASOULIS E | 2002 | Eur J Cancer2002，38，18： | 1 |
| 11 | Diagnostic and therapeutic management of cancer of an unknown primary显示文摘 | Pavlidis N Briasoulis E Hainsworth J | 2003 | Eur J Cancer2003，39，14： | 1 |
| 12 | Diagnostic and therapeutic management of cancer of an unknown primary显示文摘 | Pavlidis N Briasoulis E Hainsworth J | 2003 | Eur J Cancer2003，39，14： | 1 |
| 13 | Diagnostic and therapeutic management of cancer of an unknown primary显示文摘 | Briasoulis E Hainsworth J | 2003 | Eur J Cancer2003，39，14： | 1 |
| 14 | Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circum- vention strategies 显示文摘 | Murray S Briasoulis E Linardou H | 2012 | Cancer Treatment Reviews2012，38，7： | 1 |
| 15 | A novel pericardial ef{usion scoring index to guide decision for drainage显示文摘 | Halpern DG Argulian E Briasoulis A | 2012 | Crit Pathw Cardiol2012，11，2： | 1 |
| 16 | Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metaUothionein in primary invasive breast cancer 显示文摘 | loachim E Tsanou E Briasoulis E | 2003 | Breast2003，12，2： | 1 |
| 17 | Clinicopathological study of the expression of hsp27,pS2,cathepsin D and metallothionein in primary invasive breast cancer显示文摘 | Ioachim E Tsanou E Briasoulis E | 2003 | Breast2003，12，2： | 1 |
| 18 | Immunohistochemical expression of extracellular matrix components tenascin,fibronectin,collagen type Ⅳ and laminin in breast cancer:their prognostic value and role in tumour invasion and progression显示文摘 | Ioachim E Charchanti A Briasoulis E | 2002 | Eur J Cancer2002，38，18： | 1 |
| 19 | Treatment of non-small cell lung cancer with gefitinib (Iressa,ZD1839):the Greek experience with a compassionate-use program显示文摘 | Razis E Skarles D Briasoulis E | 2005 | Anticancer Drugs2005，16，2： | 1 |
| 20 | Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel显示文摘 | Briasoulis E Karavasilis V Tzamakou E | | 0，，05： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员